When we invest, we’re invested.

Our promise to founders

There’s more to explore

Our Stories

The Next Identity Crisis Is Non-Human: Our Investment in Astrix

Astrix is tackling the challenge of securing non-human identities head-on by addressing the full lifecycle of NHIs, ensuring that enterprises can automate confidently and securely.

→
2024: The State of Generative AI in the Enterprise
→
The New Cybersecurity Checklist: Five Things We Look for in AI-First Security Companies
→

Partnership
is our
purpose.
Rewiring the Financial Data Graph: Our Series A Investment in Numeric
→
Scatter plot graphic of Anthology Fund company descriptions
$100M Anthology Fund 60-Day Update: A View Into AI Innovators
→
AI talent thumbnail
AI Compensation Trends: The Real Cost of Top 1% AI Technical Talent
→

Beyond Bots: How AI Agents Are Driving the Next Wave of Enterprise Automation

Unlike previous generations of software that primarily addressed low-level, sequential tasks that could be robotically executed, new cognitive architectures enable AI agents to dynamically automate end-to-end processes.

→

AI Agents: A New Architecture for Enterprise Automation

With new building blocks like multi-step logic, external memory, and access to third-party tools and APIs, the next wave of agents is expanding the frontier of AI capabilities to enable end-to-end process automation.

→
Anthology Fund
→
Reimagining Smart Car Repair: Our Investment in Kinetic
→
Welcoming Our Newest Consumer Investor, C.C. Gong
→
Early-Stage Sales: Four Tips for Startups
→

Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines

Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.

→

Join a
Menlo-backed
company.
No Weak Links: Collaboration Will Strengthen the Supply Chain
→
When we’re in,
we’re ALL IN.
all-in-1